drugset / Trial / NCT05339542

Platelet Rich Plasma in Plantar Fasciitis

NCT05339542

Completed 98 enrolled Minia University
RandomizedParallel-groupDouble-blindTreatment

Summary

a number of patient diagnosed as degenerative plantar fasciitis will be collected and divided into two groups, group I will be injected by platelet rich plasma and group II will be injected methylprednisolone

Timeline

Start
2022-03-10
Primary completion
2022-07-01
Completion
2022-07-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 80 mg Other
Subject Platelet Rich Plasma Other / unclassified Other
Comparator Lidocaine Other / unclassified 1 ml Other

Indications